Previous Article | Next Article ![]()
Journal of Virology, April 2008, p. 3624-3631, Vol. 82, No. 7
0022-538X/08/$08.00+0 doi:10.1128/JVI.01753-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Silke Stertz,1,
,
Daniel Grimm,1
John Steel,2
Adolfo García-Sastre,2
Otto Haller,1 and
Georg Kochs1*
Department of Virology, University of Freiburg, D-79008 Freiburg, Germany,1 Department of Microbiology, Mount Sinai School of Medicine, New York, New York 100292
Received 10 August 2007/ Accepted 24 December 2007
Interferon-mediated host responses are of great importance for controlling influenza A virus infections. It is well established that the interferon-induced Mx proteins possess powerful antiviral activities toward most influenza viruses. Here we analyzed a range of influenza A virus strains for their sensitivities to murine Mx1 and human MxA proteins and found remarkable differences. Virus strains of avian origin were highly sensitive to Mx1, whereas strains of human origin showed much weaker responses. Artificial reassortments of the viral components in a minireplicon system identified the viral nucleoprotein as the main target structure of Mx1. Interestingly, the recently reconstructed 1918 H1N1 "Spanish flu" virus was much less sensitive than the highly pathogenic avian H5N1 strain A/Vietnam/1203/04 when tested in a minireplicon system. Importantly, the human 1918 virus-based minireplicon system was almost insensitive to inhibition by human MxA, whereas the avian influenza A virus H5N1-derived system was well controlled by MxA. These findings suggest that Mx proteins provide a formidable hurdle that hinders influenza A viruses of avian origin from crossing the species barrier to humans. They further imply that the observed insensitivity of the 1918 virus-based replicon to the antiviral activity of human MxA is a hitherto unrecognized characteristic of the "Spanish flu" virus that may contribute to the high virulence of this unusual pandemic strain.
Published ahead of print on 16 January 2008.
J.D. and S.S. contributed equally to this work.
Present address: Department of Microbiology, Mount Sinai School of Medicine, New York, NY 10029.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»